CA2603002A1 - Matieres faconnees en forme de spheres - Google Patents

Matieres faconnees en forme de spheres Download PDF

Info

Publication number: CA2603002A1
Authority: CA; Canada
Prior art keywords: particle; composition; particles; formulation; substance
Prior art date: 2005-03-31
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA002603002A

Other languages

English (en)

Inventor

Tamar Kaully

Moshit Yaskin-Harush

Corinne Nadiv

Zachi Tenenbaum

Yael Sides

Dganit Shacham

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Rafael Advanced Defense Systems Ltd

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-03-31

Filing date

2006-03-30

Publication date

2006-10-05

2006-03-30 Application filed by Individual filed Critical Individual

2006-10-05 Publication of CA2603002A1 publication Critical patent/CA2603002A1/fr

Status Abandoned legal-status Critical Current

Links

239000000126 substance Substances 0.000 title claims abstract description 77
239000002245 particle Substances 0.000 claims abstract description 341
239000004480 active ingredient Substances 0.000 claims abstract description 29
235000013305 food Nutrition 0.000 claims abstract description 20
235000016709 nutrition Nutrition 0.000 claims abstract description 14
239000002417 nutraceutical Substances 0.000 claims abstract description 13
235000021436 nutraceutical agent Nutrition 0.000 claims abstract description 13
239000003937 drug carrier Substances 0.000 claims abstract description 11
239000002537 cosmetic Substances 0.000 claims abstract description 9
239000000203 mixture Substances 0.000 claims description 94
229930091371 Fructose Natural products 0.000 claims description 60
239000005715 Fructose Substances 0.000 claims description 59
239000000843 powder Substances 0.000 claims description 58
238000009472 formulation Methods 0.000 claims description 37
229930006000 Sucrose Natural products 0.000 claims description 34
239000005720 sucrose Substances 0.000 claims description 33
XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 claims description 25
229960003105 metformin Drugs 0.000 claims description 24
CTRLABGOLIVAIY-UHFFFAOYSA-N oxcarbazepine Chemical compound C1C(=O)C2=CC=CC=C2N(C(=O)N)C2=CC=CC=C21 CTRLABGOLIVAIY-UHFFFAOYSA-N 0.000 claims description 23
239000008194 pharmaceutical composition Substances 0.000 claims description 23
229960001816 oxcarbazepine Drugs 0.000 claims description 20
230000003287 optical effect Effects 0.000 claims description 10
150000002016 disaccharides Chemical class 0.000 claims description 8
235000013343 vitamin Nutrition 0.000 claims description 8
239000011782 vitamin Substances 0.000 claims description 8
229940088594 vitamin Drugs 0.000 claims description 8
229930003231 vitamin Natural products 0.000 claims description 8
229960004166 diltiazem Drugs 0.000 claims description 7
HSUGRBWQSSZJOP-RTWAWAEBSA-N diltiazem Chemical compound C1=CC(OC)=CC=C1[C@H]1[C@@H](OC(C)=O)C(=O)N(CCN(C)C)C2=CC=CC=C2S1 HSUGRBWQSSZJOP-RTWAWAEBSA-N 0.000 claims description 7
229910052500 inorganic mineral Inorganic materials 0.000 claims description 7
239000011707 mineral Substances 0.000 claims description 7
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 6
235000009470 Theobroma cacao Nutrition 0.000 claims description 5
150000002772 monosaccharides Chemical class 0.000 claims description 5
150000003722 vitamin derivatives Chemical class 0.000 claims description 4
235000021539 instant coffee Nutrition 0.000 claims description 3
235000013599 spices Nutrition 0.000 claims description 3
BJHIKXHVCXFQLS-UYFOZJQFSA-N fructose group Chemical group OCC(=O)[C@@H](O)[C@H](O)[C@H](O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 claims description 2
125000000185 sucrose group Chemical group 0.000 claims description 2
244000240602 cacao Species 0.000 claims 1
239000002002 slurry Substances 0.000 description 60
229960002737 fructose Drugs 0.000 description 59
RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 58
239000007788 liquid Substances 0.000 description 54
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 32
238000000034 method Methods 0.000 description 32
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 27
239000000463 material Substances 0.000 description 25
239000003814 drug Substances 0.000 description 24
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 22
238000004519 manufacturing process Methods 0.000 description 19
229940079593 drug Drugs 0.000 description 18
238000002360 preparation method Methods 0.000 description 18
238000002604 ultrasonography Methods 0.000 description 18
230000008569 process Effects 0.000 description 17
238000003756 stirring Methods 0.000 description 15
238000002474 experimental method Methods 0.000 description 13
FEDJGPQLLNQAIY-UHFFFAOYSA-N 2-[(6-oxo-1h-pyridazin-3-yl)oxy]acetic acid Chemical compound OC(=O)COC=1C=CC(=O)NN=1 FEDJGPQLLNQAIY-UHFFFAOYSA-N 0.000 description 12
229960005316 diltiazem hydrochloride Drugs 0.000 description 12
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
239000000047 product Substances 0.000 description 11
230000008901 benefit Effects 0.000 description 10
238000013270 controlled release Methods 0.000 description 10
230000000694 effects Effects 0.000 description 10
235000000346 sugar Nutrition 0.000 description 10
239000002775 capsule Substances 0.000 description 9
238000007493 shaping process Methods 0.000 description 9
238000012856 packing Methods 0.000 description 8
229920002472 Starch Polymers 0.000 description 7
239000002585 base Substances 0.000 description 7
235000013361 beverage Nutrition 0.000 description 7
239000003795 chemical substances by application Substances 0.000 description 7
-1 e.g. Substances 0.000 description 7
239000000546 pharmaceutical excipient Substances 0.000 description 7
238000012545 processing Methods 0.000 description 7
235000003599 food sweetener Nutrition 0.000 description 6
230000000670 limiting effect Effects 0.000 description 6
235000010755 mineral Nutrition 0.000 description 6
239000003765 sweetening agent Substances 0.000 description 6
239000011248 coating agent Substances 0.000 description 5
238000000576 coating method Methods 0.000 description 5
239000008107 starch Substances 0.000 description 5
235000019698 starch Nutrition 0.000 description 5
VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
244000299461 Theobroma cacao Species 0.000 description 4
239000000969 carrier Substances 0.000 description 4
238000005538 encapsulation Methods 0.000 description 4
239000002360 explosive Substances 0.000 description 4
238000000227 grinding Methods 0.000 description 4
238000000338 in vitro Methods 0.000 description 4
230000007246 mechanism Effects 0.000 description 4
230000002093 peripheral effect Effects 0.000 description 4
239000011164 primary particle Substances 0.000 description 4
239000007787 solid Substances 0.000 description 4
238000003860 storage Methods 0.000 description 4
150000008163 sugars Chemical class 0.000 description 4
239000003826 tablet Substances 0.000 description 4
238000012360 testing method Methods 0.000 description 4
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
238000004438 BET method Methods 0.000 description 3
229920002261 Corn starch Polymers 0.000 description 3
241001465754 Metazoa Species 0.000 description 3
230000002776 aggregation Effects 0.000 description 3
238000004220 aggregation Methods 0.000 description 3
238000003556 assay Methods 0.000 description 3
230000004071 biological effect Effects 0.000 description 3
238000004113 cell culture Methods 0.000 description 3
150000001875 compounds Chemical class 0.000 description 3
238000007906 compression Methods 0.000 description 3
235000005911 diet Nutrition 0.000 description 3
230000000378 dietary effect Effects 0.000 description 3
239000002552 dosage form Substances 0.000 description 3
239000000945 filler Substances 0.000 description 3
239000000796 flavoring agent Substances 0.000 description 3
235000019634 flavors Nutrition 0.000 description 3
235000013373 food additive Nutrition 0.000 description 3
239000002778 food additive Substances 0.000 description 3
238000005259 measurement Methods 0.000 description 3
239000008188 pellet Substances 0.000 description 3
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 3
239000001267 polyvinylpyrrolidone Substances 0.000 description 3
229920000036 polyvinylpyrrolidone Polymers 0.000 description 3
230000005855 radiation Effects 0.000 description 3
230000002829 reductive effect Effects 0.000 description 3
239000006188 syrup Substances 0.000 description 3
235000020357 syrup Nutrition 0.000 description 3
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
108010010803 Gelatin Proteins 0.000 description 2
241000282412 Homo Species 0.000 description 2
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
239000000654 additive Substances 0.000 description 2
239000007864 aqueous solution Substances 0.000 description 2
230000004888 barrier function Effects 0.000 description 2
239000011230 binding agent Substances 0.000 description 2
229910000019 calcium carbonate Inorganic materials 0.000 description 2
239000001913 cellulose Substances 0.000 description 2
235000010980 cellulose Nutrition 0.000 description 2
229920002678 cellulose Polymers 0.000 description 2
239000003245 coal Substances 0.000 description 2
230000006835 compression Effects 0.000 description 2
239000008120 corn starch Substances 0.000 description 2
238000010908 decantation Methods 0.000 description 2
238000011161 development Methods 0.000 description 2
238000009792 diffusion process Methods 0.000 description 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
239000008298 dragée Substances 0.000 description 2
238000001914 filtration Methods 0.000 description 2
OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
235000010855 food raising agent Nutrition 0.000 description 2
239000007789 gas Substances 0.000 description 2
230000002496 gastric effect Effects 0.000 description 2
239000000499 gel Substances 0.000 description 2
229920000159 gelatin Polymers 0.000 description 2
239000008273 gelatin Substances 0.000 description 2
235000019322 gelatine Nutrition 0.000 description 2
235000011852 gelatine desserts Nutrition 0.000 description 2
239000008187 granular material Substances 0.000 description 2
235000015243 ice cream Nutrition 0.000 description 2
230000006872 improvement Effects 0.000 description 2
239000008101 lactose Substances 0.000 description 2
239000012528 membrane Substances 0.000 description 2
229910052751 metal Inorganic materials 0.000 description 2
239000002184 metal Substances 0.000 description 2
238000012986 modification Methods 0.000 description 2
230000004048 modification Effects 0.000 description 2
235000019533 nutritive sweetener Nutrition 0.000 description 2
230000036961 partial effect Effects 0.000 description 2
230000000144 pharmacologic effect Effects 0.000 description 2
230000002035 prolonged effect Effects 0.000 description 2
230000009257 reactivity Effects 0.000 description 2
230000009467 reduction Effects 0.000 description 2
150000003839 salts Chemical class 0.000 description 2
239000002904 solvent Substances 0.000 description 2
238000001179 sorption measurement Methods 0.000 description 2
229910001220 stainless steel Inorganic materials 0.000 description 2
239000010935 stainless steel Substances 0.000 description 2
239000013589 supplement Substances 0.000 description 2
239000000725 suspension Substances 0.000 description 2
238000013268 sustained release Methods 0.000 description 2
239000012730 sustained-release form Substances 0.000 description 2
208000024891 symptom Diseases 0.000 description 2
230000002195 synergetic effect Effects 0.000 description 2
235000019640 taste Nutrition 0.000 description 2
238000009210 therapy by ultrasound Methods 0.000 description 2
238000009827 uniform distribution Methods 0.000 description 2
LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
HZLCGUXUOFWCCN-UHFFFAOYSA-N 2-hydroxynonadecane-1,2,3-tricarboxylic acid Chemical compound CCCCCCCCCCCCCCCCC(C(O)=O)C(O)(C(O)=O)CC(O)=O HZLCGUXUOFWCCN-UHFFFAOYSA-N 0.000 description 1
UJVBZCCNLAAMOV-UHFFFAOYSA-N 2h-1,2-benzothiazine Chemical class C1=CC=C2C=CNSC2=C1 UJVBZCCNLAAMOV-UHFFFAOYSA-N 0.000 description 1
AEMOLEFTQBMNLQ-UHFFFAOYSA-N 3,4,5,6-tetrahydroxyoxane-2-carboxylic acid Chemical compound OC1OC(C(O)=O)C(O)C(O)C1O AEMOLEFTQBMNLQ-UHFFFAOYSA-N 0.000 description 1
229920001817 Agar Polymers 0.000 description 1
206010002383 Angina Pectoris Diseases 0.000 description 1
241000416162 Astragalus gummifer Species 0.000 description 1
229940123208 Biguanide Drugs 0.000 description 1
XNCOSPRUTUOJCJ-UHFFFAOYSA-N Biguanide Chemical compound NC(N)=NC(N)=N XNCOSPRUTUOJCJ-UHFFFAOYSA-N 0.000 description 1
229940127291 Calcium channel antagonist Drugs 0.000 description 1
206010010904 Convulsion Diseases 0.000 description 1
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
206010013911 Dysgeusia Diseases 0.000 description 1
102000004190 Enzymes Human genes 0.000 description 1
108090000790 Enzymes Proteins 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
206010020772 Hypertension Diseases 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
206010022489 Insulin Resistance Diseases 0.000 description 1
235000019759 Maize starch Nutrition 0.000 description 1
229930195725 Mannitol Natural products 0.000 description 1
229920000168 Microcrystalline cellulose Polymers 0.000 description 1
OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
208000025371 Taste disease Diseases 0.000 description 1
229920001615 Tragacanth Polymers 0.000 description 1
230000003213 activating effect Effects 0.000 description 1
230000000996 additive effect Effects 0.000 description 1
239000002671 adjuvant Substances 0.000 description 1
239000008272 agar Substances 0.000 description 1
235000010419 agar Nutrition 0.000 description 1
229940040563 agaric acid Drugs 0.000 description 1
235000013334 alcoholic beverage Nutrition 0.000 description 1
230000001476 alcoholic effect Effects 0.000 description 1
235000010443 alginic acid Nutrition 0.000 description 1
239000000783 alginic acid Substances 0.000 description 1
229920000615 alginic acid Polymers 0.000 description 1
229960001126 alginic acid Drugs 0.000 description 1
150000004781 alginic acids Chemical class 0.000 description 1
125000003277 amino group Chemical group 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
238000010171 animal model Methods 0.000 description 1
230000003556 anti-epileptic effect Effects 0.000 description 1
239000001961 anticonvulsive agent Substances 0.000 description 1
229960003965 antiepileptics Drugs 0.000 description 1
239000003963 antioxidant agent Substances 0.000 description 1
235000006708 antioxidants Nutrition 0.000 description 1
238000010420 art technique Methods 0.000 description 1
229960005070 ascorbic acid Drugs 0.000 description 1
235000010323 ascorbic acid Nutrition 0.000 description 1
239000011668 ascorbic acid Substances 0.000 description 1
235000015173 baked goods and baking mixes Nutrition 0.000 description 1
239000011324 bead Substances 0.000 description 1
230000005540 biological transmission Effects 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
239000008280 blood Substances 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
210000001124 body fluid Anatomy 0.000 description 1
239000010839 body fluid Substances 0.000 description 1
210000004556 brain Anatomy 0.000 description 1
239000000480 calcium channel blocker Substances 0.000 description 1
239000001506 calcium phosphate Substances 0.000 description 1
229910000389 calcium phosphate Inorganic materials 0.000 description 1
235000011010 calcium phosphates Nutrition 0.000 description 1
FFGPTBGBLSHEPO-UHFFFAOYSA-N carbamazepine Chemical class C1=CC2=CC=CC=C2N(C(=O)N)C2=CC=CC=C21 FFGPTBGBLSHEPO-UHFFFAOYSA-N 0.000 description 1
150000001720 carbohydrates Chemical class 0.000 description 1
235000014633 carbohydrates Nutrition 0.000 description 1
235000013339 cereals Nutrition 0.000 description 1
239000002738 chelating agent Substances 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
230000001684 chronic effect Effects 0.000 description 1
235000016213 coffee Nutrition 0.000 description 1
235000013353 coffee beverage Nutrition 0.000 description 1
239000003086 colorant Substances 0.000 description 1
235000013409 condiments Nutrition 0.000 description 1
238000007596 consolidation process Methods 0.000 description 1
238000010276 construction Methods 0.000 description 1
230000001276 controlling effect Effects 0.000 description 1
230000036461 convulsion Effects 0.000 description 1
239000012809 cooling fluid Substances 0.000 description 1
239000000110 cooling liquid Substances 0.000 description 1
239000013078 crystal Substances 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
239000003405 delayed action preparation Substances 0.000 description 1
230000003111 delayed effect Effects 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
238000000151 deposition Methods 0.000 description 1
238000001514 detection method Methods 0.000 description 1
238000005474 detonation Methods 0.000 description 1
235000013681 dietary sucrose Nutrition 0.000 description 1
239000003085 diluting agent Substances 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000035475 disorder Diseases 0.000 description 1
239000006185 dispersion Substances 0.000 description 1
238000004090 dissolution Methods 0.000 description 1
238000001035 drying Methods 0.000 description 1
238000010410 dusting Methods 0.000 description 1
235000013399 edible fruits Nutrition 0.000 description 1
230000002526 effect on cardiovascular system Effects 0.000 description 1
239000003995 emulsifying agent Substances 0.000 description 1
230000001804 emulsifying effect Effects 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
230000003628 erosive effect Effects 0.000 description 1
239000007888 film coating Substances 0.000 description 1
238000009501 film coating Methods 0.000 description 1
239000012467 final product Substances 0.000 description 1
235000013312 flour Nutrition 0.000 description 1
239000012530 fluid Substances 0.000 description 1
239000011888 foil Substances 0.000 description 1
229960000304 folic acid Drugs 0.000 description 1
235000019152 folic acid Nutrition 0.000 description 1
239000011724 folic acid Substances 0.000 description 1
230000037406 food intake Effects 0.000 description 1
239000012458 free base Substances 0.000 description 1
210000001035 gastrointestinal tract Anatomy 0.000 description 1
239000008103 glucose Substances 0.000 description 1
125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
230000002641 glycemic effect Effects 0.000 description 1
208000019622 heart disease Diseases 0.000 description 1
239000007970 homogeneous dispersion Substances 0.000 description 1
235000012907 honey Nutrition 0.000 description 1
239000003906 humectant Substances 0.000 description 1
239000000416 hydrocolloid Substances 0.000 description 1
229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
229940126904 hypoglycaemic agent Drugs 0.000 description 1
230000004941 influx Effects 0.000 description 1
230000031891 intestinal absorption Effects 0.000 description 1
230000000968 intestinal effect Effects 0.000 description 1
150000002500 ions Chemical class 0.000 description 1
230000007794 irritation Effects 0.000 description 1
208000028867 ischemia Diseases 0.000 description 1
238000002372 labelling Methods 0.000 description 1
230000002045 lasting effect Effects 0.000 description 1
238000002386 leaching Methods 0.000 description 1
235000020094 liqueur Nutrition 0.000 description 1
231100000053 low toxicity Toxicity 0.000 description 1
VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
239000000347 magnesium hydroxide Substances 0.000 description 1
229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
238000012423 maintenance Methods 0.000 description 1
239000000594 mannitol Substances 0.000 description 1
235000010355 mannitol Nutrition 0.000 description 1
235000019656 metallic taste Nutrition 0.000 description 1
229920000609 methyl cellulose Polymers 0.000 description 1
239000001923 methylcellulose Substances 0.000 description 1
235000010981 methylcellulose Nutrition 0.000 description 1
229940016286 microcrystalline cellulose Drugs 0.000 description 1
235000019813 microcrystalline cellulose Nutrition 0.000 description 1
239000008108 microcrystalline cellulose Substances 0.000 description 1
235000013336 milk Nutrition 0.000 description 1
239000008267 milk Substances 0.000 description 1
210000004080 milk Anatomy 0.000 description 1
238000002156 mixing Methods 0.000 description 1
208000031225 myocardial ischemia Diseases 0.000 description 1
210000004165 myocardium Anatomy 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
235000013615 non-nutritive sweetener Nutrition 0.000 description 1
102000039446 nucleic acids Human genes 0.000 description 1
108020004707 nucleic acids Proteins 0.000 description 1
150000007523 nucleic acids Chemical class 0.000 description 1
230000035764 nutrition Effects 0.000 description 1
235000020939 nutritional additive Nutrition 0.000 description 1
239000011236 particulate material Substances 0.000 description 1
239000012466 permeate Substances 0.000 description 1
239000007971 pharmaceutical suspension Substances 0.000 description 1
230000000704 physical effect Effects 0.000 description 1
230000001766 physiological effect Effects 0.000 description 1
239000006187 pill Substances 0.000 description 1
230000036470 plasma concentration Effects 0.000 description 1
239000004033 plastic Substances 0.000 description 1
229920003023 plastic Polymers 0.000 description 1
229920001223 polyethylene glycol Polymers 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
229920001592 potato starch Polymers 0.000 description 1
230000003389 potentiating effect Effects 0.000 description 1
239000000955 prescription drug Substances 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
102000004169 proteins and genes Human genes 0.000 description 1
108090000623 proteins and genes Proteins 0.000 description 1
230000000541 pulsatile effect Effects 0.000 description 1
239000002994 raw material Substances 0.000 description 1
230000001105 regulatory effect Effects 0.000 description 1
230000003014 reinforcing effect Effects 0.000 description 1
230000008439 repair process Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
230000004043 responsiveness Effects 0.000 description 1
229940100486 rice starch Drugs 0.000 description 1
238000004626 scanning electron microscopy Methods 0.000 description 1
238000007789 sealing Methods 0.000 description 1
239000000377 silicon dioxide Substances 0.000 description 1
235000020374 simple syrup Nutrition 0.000 description 1
210000002460 smooth muscle Anatomy 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
235000015424 sodium Nutrition 0.000 description 1
235000010413 sodium alginate Nutrition 0.000 description 1
239000000661 sodium alginate Substances 0.000 description 1
229940005550 sodium alginate Drugs 0.000 description 1
235000014214 soft drink Nutrition 0.000 description 1
239000012439 solid excipient Substances 0.000 description 1
239000000600 sorbitol Substances 0.000 description 1
235000011496 sports drink Nutrition 0.000 description 1
239000007858 starting material Substances 0.000 description 1
230000003068 static effect Effects 0.000 description 1
238000005728 strengthening Methods 0.000 description 1
239000000758 substrate Substances 0.000 description 1
230000003746 surface roughness Effects 0.000 description 1
230000004083 survival effect Effects 0.000 description 1
229940124597 therapeutic agent Drugs 0.000 description 1
229940126585 therapeutic drug Drugs 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
231100000419 toxicity Toxicity 0.000 description 1
230000001988 toxicity Effects 0.000 description 1
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
ZSDSQXJSNMTJDA-UHFFFAOYSA-N trifluralin Chemical compound CCCN(CCC)C1=C([N+]([O-])=O)C=C(C(F)(F)F)C=C1[N+]([O-])=O ZSDSQXJSNMTJDA-UHFFFAOYSA-N 0.000 description 1
208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
235000015112 vegetable and seed oil Nutrition 0.000 description 1
239000008158 vegetable oil Substances 0.000 description 1
239000011800 void material Substances 0.000 description 1
229940100445 wheat starch Drugs 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F23/00—Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
- B01F23/50—Mixing liquids with solids
- B01F23/53—Mixing liquids with solids using driven stirrers
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F23/00—Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
- B01F23/50—Mixing liquids with solids
- B01F23/55—Mixing liquids with solids the mixture being submitted to electrical, sonic or similar energy
- B01F23/551—Mixing liquids with solids the mixture being submitted to electrical, sonic or similar energy using vibrations
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F27/00—Mixers with rotary stirring devices in fixed receptacles; Kneaders
- B01F27/80—Mixers with rotary stirring devices in fixed receptacles; Kneaders with stirrers rotating about a substantially vertical axis
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F31/00—Mixers with shaking, oscillating, or vibrating mechanisms
- B01F31/80—Mixing by means of high-frequency vibrations above one kHz, e.g. ultrasonic vibrations
- B01F31/83—Mixing by means of high-frequency vibrations above one kHz, e.g. ultrasonic vibrations comprising a supplementary stirring element
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F31/00—Mixers with shaking, oscillating, or vibrating mechanisms
- B01F31/80—Mixing by means of high-frequency vibrations above one kHz, e.g. ultrasonic vibrations
- B01F31/86—Mixing by means of high-frequency vibrations above one kHz, e.g. ultrasonic vibrations with vibration of the receptacle or part of it
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/0053—Details of the reactor
- B01J19/0066—Stirrers
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/008—Processes for carrying out reactions under cavitation conditions
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/08—Processes employing the direct application of electric or wave energy, or particle radiation; Apparatus therefor
- B01J19/10—Processes employing the direct application of electric or wave energy, or particle radiation; Apparatus therefor employing sonic or ultrasonic vibrations
- B—PERFORMING OPERATIONS; TRANSPORTING
- B02—CRUSHING, PULVERISING, OR DISINTEGRATING; PREPARATORY TREATMENT OF GRAIN FOR MILLING
- B02C—CRUSHING, PULVERISING, OR DISINTEGRATING IN GENERAL; MILLING GRAIN
- B02C19/00—Other disintegrating devices or methods
- B02C19/18—Use of auxiliary physical effects, e.g. ultrasonics, irradiation, for disintegrating
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00049—Controlling or regulating processes
- B01J2219/00051—Controlling the temperature
- B01J2219/00074—Controlling the temperature by indirect heating or cooling employing heat exchange fluids
- B01J2219/00087—Controlling the temperature by indirect heating or cooling employing heat exchange fluids with heat exchange elements outside the reactor
- B01J2219/00094—Jackets
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/08—Processes employing the direct application of electric or wave energy, or particle radiation; Apparatus therefor
- B01J2219/0873—Materials to be treated
- B01J2219/0881—Two or more materials
- B01J2219/0888—Liquid-liquid
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/08—Processes employing the direct application of electric or wave energy, or particle radiation; Apparatus therefor
- B01J2219/0873—Materials to be treated
- B01J2219/0881—Two or more materials
- B01J2219/089—Liquid-solid
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/19—Details relating to the geometry of the reactor
- B01J2219/192—Details relating to the geometry of the reactor polygonal
- B01J2219/1923—Details relating to the geometry of the reactor polygonal square or square-derived

Landscapes

Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Toxicology (AREA)
Life Sciences & Earth Sciences (AREA)
Dispersion Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Zoology (AREA)
Dermatology (AREA)
Engineering & Computer Science (AREA)
Food Science & Technology (AREA)
Medicinal Preparation (AREA)
Physical Or Chemical Processes And Apparatus (AREA)

CA002603002A 2005-03-31 2006-03-30 Matieres faconnees en forme de spheres Abandoned CA2603002A1 (fr)

Applications Claiming Priority (7)

Application Number	Priority Date	Filing Date	Title
IL167772		2005-03-31
IL16777205		2005-03-31
US70876605P	2005-08-17	2005-08-17
US70876505P	2005-08-17	2005-08-17
US60/708,766		2005-08-17
US60/708,765		2005-08-17
PCT/IL2006/000404 WO2006103672A2 (fr)	2005-03-31	2006-03-30	Matieres façonnees en forme de spheres

Publications (1)

Publication Number	Publication Date
CA2603002A1 true CA2603002A1 (fr)	2006-10-05

Family

ID=36753998

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
CA002603031A Abandoned CA2603031A1 (fr)	2005-03-31	2006-03-30	Appareil permettant le traitement par ultrasons de particules
CA002603002A Abandoned CA2603002A1 (fr)	2005-03-31	2006-03-30	Matieres faconnees en forme de spheres

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
CA002603031A Abandoned CA2603031A1 (fr)	2005-03-31	2006-03-30	Appareil permettant le traitement par ultrasons de particules

Country Status (5)

Country	Link
US (1)	US20090162447A1 (fr)
EP (2)	EP1863451A2 (fr)
AU (2)	AU2006228536A1 (fr)
CA (2)	CA2603031A1 (fr)
WO (2)	WO2006103671A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20210051972A1 (en) *	2019-08-21	2021-02-25	Amorepacific Corporation	Processed products of tea and method for manufacturing the same
US11612172B2 (en)	2018-10-25	2023-03-28	Amorepacific Corporation	Processed products of tea with quick dispersibility in water and method for manufacturing processed products of tea

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PL1937086T3 (pl) *	2005-09-23	2014-05-30	Simplot Australia Pty Ltd	Obróbka produktów spożywczych
DE102008034666B4 (de) *	2008-07-22	2021-02-25	GM Global Technology Operations LLC (n. d. Ges. d. Staates Delaware)	Verfahren zur Aktivierung von Metallhydridpartikeln oder von Partikeln von Metallen, die Metallhydridvorläufer sind
US8166819B2 (en) *	2008-07-24	2012-05-01	Northrop Grumman Systems Corporation	Standing wave field induced force
US9138309B2 (en)	2010-02-05	2015-09-22	Allergan, Inc.	Porous materials, methods of making and uses
US9205577B2 (en) *	2010-02-05	2015-12-08	Allergan, Inc.	Porogen compositions, methods of making and uses
US11202853B2 (en) *	2010-05-11	2021-12-21	Allergan, Inc.	Porogen compositions, methods of making and uses
DE102010025742B4 (de)	2010-06-30	2013-05-29	Hebumedical Gmbh	Bipolare Pinzette
CA2882302A1 (fr) *	2012-08-20	2014-02-27	Christopher T. Banus	Appareil a vibrations pour le melange de liquides non miscibles et pour le melange de poudres avec des liquides ou d'autres poudres
CN103657818A (zh) *	2013-11-30	2014-03-26	成都欣华源科技有限责任公司	超声破碎杯
US20230201086A1 (en) *	2018-02-07	2023-06-29	Daicel Corporation	Cellulose acetate particles, cosmetic composition, and method for producing cellulose acetate particles
WO2020160323A2 (fr) *	2019-01-31	2020-08-06	Elektrofi, Inc.	Formation et morphologie de particules
WO2022014084A1 (fr) *	2020-07-13	2022-01-20	株式会社ダイセル	Particules d'acétate de cellulose, composition cosmétique et procédé de production de particules d'acétate de cellulose

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2578505A (en) *	1948-03-02	1951-12-11	Sperry Prod Inc	Supersonic agitation
US4118649A (en) *	1977-05-25	1978-10-03	Rca Corporation	Transducer assembly for megasonic cleaning
US5376386A (en) *	1990-01-24	1994-12-27	British Technology Group Limited	Aerosol carriers
KR100221695B1 (ko) *	1991-08-12	1999-09-15	그린 마틴, 브라이언 쥐 테슬리	약학적 구상 제형
DE4228618A1 (de) *	1992-08-28	1994-03-03	Hoechst Ag	Reaktor zum Durchführen von chemischen Reaktionen
BR9406396A (pt) *	1993-05-11	1996-02-27	Sonosep Biotech Inc	Ressonador piezoelétrico em múltiplas camadas para a separaçao de partículas em suspensao
GB9819272D0 (en) *	1998-09-03	1998-10-28	Andaris Ltd	Microparticles
ITMI991582A1 (it) *	1999-07-16	2001-01-16	Chiesi Farma Spa	Polveri costituite da particelle aventi la superficie perfettamente levigata da utilizzare come veicoli per la preparazione di miscele inala
US20020015730A1 (en) *	2000-03-09	2002-02-07	Torsten Hoffmann	Pharmaceutical formulations and method for making

2006
- 2006-03-30 WO PCT/IL2006/000403 patent/WO2006103671A1/fr not_active Ceased
- 2006-03-30 CA CA002603031A patent/CA2603031A1/fr not_active Abandoned
- 2006-03-30 EP EP06728207A patent/EP1863451A2/fr not_active Withdrawn
- 2006-03-30 WO PCT/IL2006/000404 patent/WO2006103672A2/fr not_active Ceased
- 2006-03-30 EP EP06728206A patent/EP1885484A1/fr not_active Withdrawn
- 2006-03-30 AU AU2006228536A patent/AU2006228536A1/en not_active Abandoned
- 2006-03-30 AU AU2006228535A patent/AU2006228535A1/en not_active Abandoned
- 2006-03-30 US US11/887,630 patent/US20090162447A1/en not_active Abandoned
- 2006-03-30 CA CA002603002A patent/CA2603002A1/fr not_active Abandoned

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US11612172B2 (en)	2018-10-25	2023-03-28	Amorepacific Corporation	Processed products of tea with quick dispersibility in water and method for manufacturing processed products of tea
US20210051972A1 (en) *	2019-08-21	2021-02-25	Amorepacific Corporation	Processed products of tea and method for manufacturing the same
US11653665B2 (en) *	2019-08-21	2023-05-23	Amorepacific Corporation	Processed products of tea and method for manufacturing the same

Also Published As

Publication number	Publication date
WO2006103671A1 (fr)	2006-10-05
AU2006228536A1 (en)	2006-10-05
WO2006103672A2 (fr)	2006-10-05
AU2006228535A1 (en)	2006-10-05
EP1885484A1 (fr)	2008-02-13
US20090162447A1 (en)	2009-06-25
EP1863451A2 (fr)	2007-12-12
CA2603031A1 (fr)	2006-10-05
WO2006103672A3 (fr)	2007-06-07

Publication	Publication Date	Title
US20090162447A1 (en)	2009-06-25	Spherically Shaped Substances
JP5439366B2 (ja)	2014-03-12	偏析防止効果に優れるセルロース粉末及びその組成物
ES2311001T3 (es)	2009-02-01	Uso en ayunas de composiciones farmaceuticas que comprenden oxcarbazepina.
NZ539277A (en)	2008-04-30	Pharmaceutical product comprising a therapeutically active agent together with a pharmaceutical excipient for use with poorly water-soluble therapeutically active agents
NO342285B1 (no)	2018-04-30	Jern (III)-basert fosfatadsorbent, fremgangsmåte for fremstilling derav, anvendelser derav og farmasøytisk preparat inneholdende nevnte adsorbent.
WO2012002253A1 (fr)	2012-01-05	Particules composites qui contiennent à la fois de la cellulose et un composé inorganique
CA2306005C (fr)	2004-04-06	Preparation de gel contenant des sulfonates de polystyrene
TW201720428A (zh)	2017-06-16	包含纖維素、無機化合物及羥丙基纖維素之複合粒子
CN117467166A (zh)	2024-01-30	一种抑制堆积产生的方法
US20140079786A1 (en)	2014-03-20	Fiber Spheres
CN112770779A (zh)	2021-05-07	纤维素组合物、片剂及口腔崩解片
NO173280B (no)	1993-08-16	Fremgangsmaate for fremstilling av colestipolhydroklorid
Arida et al.	1999	Development of Sustained‐Release Ibuprofen Microspheres Using Solvent Evaporation Technique
CN104490801A (zh)	2015-04-08	一种适用于婴幼儿及儿童的可压碎片及其制备方法
KR20150013792A (ko)	2015-02-05	당뇨병 또는 당뇨병 전증을 관리하기 위한 조성물 및 방법
RU1837879C (ru)	1993-08-30	Композици , обладающа противогиперхолестеринемическим действием
JP2005255617A (ja)	2005-09-22	微粒子状活性成分および多孔質セルロース凝集体含有固形製剤組成物
JP2024031958A (ja)	2024-03-07	プレバイオティクスを含有するエルゴチオネインマイクロカプセル構造と、その調製方法、使用法及び経口剤形

Legal Events

Date	Code	Title	Description
2012-03-30	FZDE	Discontinued